Hope for the hygiene hypothesis: When the dirt hits the fan

Journal of Asthma

Volumn 42, Issue 4, 2005, Pages 225-247

  Borchers, Andrea T ^a   Keen, Carl L ^b   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergic rhinitis; Asthma; Atopic dermatitis; Atopic diseases; Childhood infections; Hygiene hypothesis; Microflora

Indexed keywords

ALLERGIC DISEASE; ALLERGIC RHINITIS; AMBIENT AIR; ATOPIC DERMATITIS; ATOPY; CHILDHOOD DISEASE; CONTROLLED STUDY; DEVELOPED COUNTRY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; GENETIC ANALYSIS; HUMAN; HYGIENE; HYPOTHESIS; OUTPATIENT DEPARTMENT; PREVALENCE; REVIEW;

ASTHMA; CLINICAL TRIALS; DERMATITIS, ATOPIC; DEVELOPED COUNTRIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTION; HUMANS; HYGIENE; HYPERSENSITIVITY; INCIDENCE; PREVALENCE; RHINITIS, ALLERGIC, PERENNIAL;

EID: 22044444746     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1081/JAS-200051302     Document Type: Review

References (224)

1. Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in North Europe: an international questionnaire study. J Am Acad Dermatol 1996; 34(5 Pt 1):760-764.
2. Lewis S, Butland B, Strachan D, Bynner J, Richards D, Butler N, Britton J. Study of the aetiology of wheezing illness at age 16 in two national British birth cohorts. Thorax 1996; 51(7):670-676.
3. von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 1998; 351(9106):862-866.
4. von Mutius E. The rising trends in asthma and allergic disease. Clin Exp Allergy 1998; 28(suppl 5):45-49, discussion 50-41.
5. Linneberg A, Nielsen NH, Madsen F, Frølund L, Dirksen A, Jørgensen T. Increasing prevalence of allergic rhinitis symptoms in an adult Danish population. Allergy 1999; 54(11):1194-1198.
6. Bråb̈ack L, Hjern A, Rasmussen F. Trends in asthma, allergic rhinitis and eczema among Swedish conscripts from farming and non-farming environments. A nationwide study over three decades. Clin Exp Allergy 2004; 34(1):38-43.
7. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351(9111):1225-1232.
8. Nyan OA, Walraven GE, Banya WA, Milligan P, Van Der Sande M, Ceesay SM, Del Prete G, McAdam KP. Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities. Clin Exp Allergy 2001; 31(11):1672-1678.
9. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299(6710):1259-1260.
10. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17(3):138-146.
11. Chaouat G, Zourbas S, Ostojic S, Lappree-Delage G, Dubanchet S, Ledee N, Martal J. A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002; 53(1-2):241-256.
12. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14(7):353-356.
13. Prescott SL, Macaubas C, Holt BJ, Smallacombe TB, Loh R, Sly PD, Hoir PG. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998; 160(10):4730-4737.
14. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999; 353(9148):196-200.
15. Holt PG, O'Keeffe P, Holt BJ, Upham JW, Baron-Hay MJ, Suphioglu C, Knox B, Stewart GA, Thomas WR, Sly PD. T-cell "priming" against environmental allergens in human neonates: sequential deletion of food antigen reactivity during infancy with concomitant expansion of responses to ubiquitous inhalant allergens. Pediatr Allergy Immunol 1995; 6(2):85-90.
16. Yabuhara A, Macaubas C, Prescott SL, Venaille TJ, Holt BJ, Habre W, Sly PD, Holt PG. Th2-polarized immunological memory to inhalant allergens in atopics is established during infancy and early childhood. Clin Exp Allergy 1997; 27(11):1261-1269.
17. Smart JM, Suphioglu C, Kemp AS. Age-related T cell responses to allergens in childhood. Clin Exp Allergy 2003; 33(3):317-324.
18. Räsänen M, Laitinen T, Kaprio J, Koskenvuo M, Laitinen LA. Hay fever, asthma and number of older siblings-a twin study. Clin Exp Allergy 1997; 27(5):515-518.
19. Matricardi PM, Franzinelli F, Franco A, Caprio G, Murru F, Cioffi D, Ferrigno L, Palermo A, Ciccarelli N, Rosmini F. Sibship size, birth order, and atopy in 11,371 Italian young men. J Allergy Clin Immunol 1998; 101(4 Pt 1):439-444.
20. Bodner C, Godden D, Seaton A, The Aberdeen WHEASE Group. Family size, childhood infections and atopic diseases. Thorax 1998; 53(1):28-32.
21. Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000; 343(8):538-543.
22. Jarvis D, Chinn S, Luczynska C, Burney P. The association of family size with atopy and atopic disease. Clin Exp Allergy 1997; 27(3):240-245.
23. Bernsen RMD, de Jongste JC, van der Wouden JC. Birth order and sibship size as independent risk factors for asthma, allergy, and eczema. Pediatr Allergy Immunol 2003; 14(6):464-469.
24. Wickens KL, Crane J, Kemp TJ, Lewis SJ, D'Souza WJ, Sawyer GM, Stone ML, Tohill SJ, Kennedy JC, Slater TM, Pearce NE. Family size, infections, and asthma prevalence in New Zealand children. Epidemiology 1999; 10(6):699-705.
25. Infante-Rivard C, Amre D, Gautrin D, Malo JL. Family size, day-care attendance, and breastfeeding in relation to the incidence of childhood asthma. Am J Epidemiol 2001; 153(7):653-658.
26. Marshall AH, Owen V, Jones NS. More siblings, less hay fever: more evidence. Clin Otolaryngol 2002; 27(5):352-358.
27. Strachan DP, Harkins LS, Golding J. Sibship size and self-reported inhalant allergy among adult women. Alspac Study Team. Clin Exp Allergy 1997; 27(2):151-155.
28. Svanes C, Jarvis D, Chinn S, Burney P. Childhood environment and adult atopy: results from the European community respiratory health survey. J Allergy Clin Immunol 1999; 103(3 Pt 1):415-420.
29. Bråbäck L, Breborowicz A, Julge K, Knutsson A, Riikjärv MA, Vasar M, Björkstén B. Risk factors for respiratory symptoms and atopic sensitisation in the Baltic area. Arch Dis Child 1995; 72(6):487-493.
30. Ponsonby AL, Couper D, Dwyer T, Carmichael A, Kemp A. Relationship between early life respiratory illness, family size over time, and the development of asthma and hay fever: a seven year follow up study. Thorax 1999; 54(8):664-669.
31. Krause TG, Hviid A, Koch A, Friborg J, Hjuler T, Wohlfahrt J, Olsen OR, Kristensen B, Melbye M. BCG vaccination and risk of atopy. JAMA 2003; 289(8):1012-1015.
32. Strachan DP, Taylor EM, Carpenter RG. Family structure, neonatal infection, and hay fever in adolescence. Arch Dis Child 1996; 74(5):422-426.
33. Pekkanen J, Remes S, Kajosaari M, Husman T, Soininen L. Infections in early childhood and risk of atopic disease. Acta Paediatr 1999; 88(7):710-714.
34. Kilpelainen M, Terho EO, Helenius H, Koskenvuo M. Farm environment in childhood prevents the development of allergies. Clin Exp Allergy 2000; 30(2):201-208.
35. Butland BK, Strachan DP, Lewis S, Bynner J, Butler N, Britton J. Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts. BMJ 1997; 315(7110):717-721.
36. Olesen AB, Ellingsen AR, Diesen H, Juul S, Thestrup-Pedersen K. Atopic dermatitis and birth factors: historical follow up by record linkage. BMJ 1997; 314(7086):1003-1008.
37. Sunyer J, Anto JM, Kogevinas M, Barcelo MA, Soriano JB, Tobias A, Muniozguren N, Martinez-Moratalla J, Payo F, Maldonado JA. Risk factors for asthma in young adults. Spanish group of the European community respiratory health survey. Eur Respir J 1997; 10(11):2490-2494.
38. Rona RJ, Duran-Tauleria E, Chinn S. Family size, atopic disorders in parents, asthma in children, and ethnicity. J Allergy Clin Immunol 1997; 99(4):454-460.
39. Sears MR, Holdaway MD, Flannery EM, Herbison GP, Silva PA. Parental and neonatal risk factors for atopy, airway hyper-responsiveness, and asthma. Arch Dis Child 1996; 75(5):392-398.
40. Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996; 312(7040):1195-1199.
41. von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Reitmeir P, Thiemann HH. Skin test reactivity and number of siblings. BMJ 1994; 308(6930):692-695.
42. Strachan DP, Harkins LS, Johnston ID, Anderson HR. Childhood antecedents of allergic sensitization in young British adults. J Allergy Clin Immunol 1997; 99(1 Pt 1):6-12.
43. Matricardi PM, Rosmini F, Ferrigno L, Nisini R, Rapicetta M, Chionne P, Stroffolini T, Pasquini P, D'Amelio R. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997; 314(7086):999-1003.
44. Koppelman GH, Jansen DF, Scheuten JP, van der Heide S, Bleecker ER, Meyers DA, Postma DS. Sibling effect on atopy in children of patients with asthma. Clin Exp Allergy 2003; 33(2):170-175.
45. Farooqi IS, Hopkin JM. Early childhood infection and atopic disorder. Thorax 1998; 53(11):927-932.
46. Haby MM, Marks GB, Peat JK, Leeder SR. Daycare attendance before the age of two protects against atopy in preschool age children. Pediatr Pulmonol 2000; 30(5):377-384.
47. Kuyucu S, Saraclar Y, Tuncer A, Sackesen C, Adalioglu G, Sümbüloglu V, Sekerel BE. Determinants of atopic sensitization in Turkish school children: effects of pre- and post-natal events and maternal atopy. Pediatr Allergy Immunol 2004; 15:62-71.
48. Mattes J, Karmaus W, Moseler M, Frischer T, Kuehr J. Accumulation of atopic disorders within families: a sibling effect only in the offspring of atopic fathers. Clin Exp Allergy 1998; 28(12):1480-1486.
49. Karmaus W, Botezan C. Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epidemiol Community Health 2002; 56(3):209-217.
50. Lewis SA, Britton JR. Measles infection, measles vaccination and the effect of birth order in the aetiology of hay fever. Clin Exp Allergy 1998; 28(12):1493-1500.
51. Wickens K, Crane J, Pearce N, Beasley R. The magnitude of the effect of smaller family sizes on the increase in the prevalence of asthma and hay fever in the United Kingdom and New Zealand. J Allergy Clin Immunol 1999; 104(3 Pt 1):554-558.
52. Backman A, Björkstén F, Ilmonen S, Juntunen K, Suoniemi I. Do infections in infancy affect sensitization to airborne allergens and development of atopic disease? A retrospective study of seven-year-old children. Allergy 1984; 39(4):309-315.
53. Marbury MC, Maldonado G, Waller L. Lower respiratory illness, recurrent wheezing, and day care attendance. Am J Respir Crit Care Med 1997; 155(1):156-161.
54. Nystad W, Skrondal A, Magnus P. Day care attendance, recurrent respiratory tract infections and asthma. Int J Epidemiol 1999; 28(5):882-887.
55. Krämer U, Heinrich J, Wjst M, Wichmann HE. Age of entry to day nursery and allergy in later childhood. Lancet 1999; 353(9151):450-454.
56. Nafstad P, Magnus P, Jaakkola JJ. Early respiratory infections and childhood asthma. Pediatrics 2000; 106(3):E38.
57. von Mutius E, Illi S, Hirsch T, Leupold W, Keil U, Weiland SK. Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children. Eur Respir J 1999; 14(1):4-11.
58. Eager P, Westergaard T, Rostgaard K, Hjalgrim H, Melbye M. Age at childhood infections and risk of atopy. Thorax 2002; 57(5):379-382.
59. Matricardi PM, Rosmini F, Riondino S, Fortini M, Ferrigno L, Rapicetta M, Bonini S. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 2000; 320(7232):412-417.
60. Illi S, von Mutius E, Lau S, Bergmann R, Niggemann B, Sommerfeld C, Wahn U. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 2001; 322: 390-395.
61. Brandenburg AH, Kleinjan A, van Het Land B, Moll HA, Timmerman HH, de Swart RL, Neijens HJ, Fokkens W, Osterhaus AD. Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J Med Virol 2000; 62(2):267-277.
62. Roman M, Calhoun WJ, Hinton KL, Avendano LF, Simon V, Escobar AM, Gaggero A, Diaz PV. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997; 156(1):190-195.
63. Bendelja K, Gagro A, Bace A, Lokar-Kolbas R, Krsulovic-Hresic V, Drazenovic V, Mlinaric-Galinovic G, Rabatic S. Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol 2000; 121(2):332-338.
64. Sung RY, Hui SH, Wong CK, Lam CW, Yin J. A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants. Eur J Pediatr 2001; 160(2):117-122.
65. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003; 168(6):633-639. Epub 2003 May 2028.
66. van der Sande MA, Kidd IM, Goetghebuer T, Martynoga RA, Magnusen A, Allen S, Weber MW, Fielding KL, Marchant A, Whittle HC. Severe respiratory syncytial virus infection in early life is associated with increased type 2 cytokine production in Gambian children. Clin Exp Allergy 2002; 32(10):1430-1435.
67. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354(9178):541-545.
68. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Björkstén B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95(4):500-505.
69. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161(5):1501-1507.
70. Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed) 1982; 284(6330):1665-1669.
71. Gehring U, Bolte G, Borte M, Bischof W, Fahlbusch B, Wichmann HE, Heinrich J. Exposure to endotoxin decreases the risk of atopic eczema in infancy: a cohort study. J Allergy Clin Immunol 2001; 108(5):847-854.
72. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M, Group Health Medical Associates. Association of non-wheezing lower respiratory tract illnesses in early life with persistently diminished serum IgE levels. Thorax 1995; 50(10):1067-1072.
73. Griffin DE, Ward BJ. Differential CD4 T cell activation in measles. J Infect Dis 1993; 168(2):275-281.
74. Moss WJ, Ryon JJ, Monze M, Griffin DE. Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J Infect Dis 2002; 186(7):879-887. Epub 2002 Sep 2013.
75. Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of 11-4 suggests induction of a Th2 response. Clin Immunol Immunopathol 1993; 67(2):171-177.
76. Schnorr JJ, Cults FT, Wheeler JG, Akramuzzaman SM, Alam MS, Azim T, Schneider-Schaulies S, ter-Meulen V. Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants. Vaccine 2001; 19(11-12):1503-1510.
77. Shaheen SO, Aaby P, Hall AJ, Barker DJP, Heyes CB, Shiell AW, Goudiaby A. Cell mediated immunity after measles in Guinea-Bissau: historical cohort study. BMJ 1996; 313(7063):969-974.
78. Atabani SF, Byrnes AA, Jaye A, Kidd IM, Magnusen AF, Whittle H, Karp CL. Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 2001; 184(1):1-9. Epub 2001 May 2030.
79. Shaheen SO, Aaby P, Hall AJ, Barker DJ, Heyes CB, Shiell AW, Goudiaby A. Measles and atopy in Guinea-Bissau. Lancet 1996; 347(9018):1792-1796.
80. Paunio M, Heinonen OP, Virtanen M, Leinikki P, Patja A, Peltola H. Measles history and atopic diseases: a population-based cross-sectional study. JAMA 2000; 283(3):343-346.
81. Kemp A, Björkstén B. Immune deviation and the hygiene hypothesis: a review of the epidemiological evidence. Pediatr Allergy Immunol 2003; 14(2):74-80.
82. Olesen AB, Juul S, Thestrup-Pedersen K. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Acta Derm-Venereol 2003; 83(6):445-450.
83. Sander B, Skansén-Saphir U, Damm O, Håkansson L, Andersson J, Andersson U. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. Immunology 1995; 86(4):512-518.
84. Schluger NW. Recent advances in our understanding of human host responses to tuberculosis. Respir Res 2001; 2(3):157-163. Epub 2001 Mar 2029.
85. Ravn P, Boesen H, Pedersen BK, Andersen P. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin. J Immunol 1997; 158(4):1949-1955.
86. Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, Corrah T, Bennett S, Wheeler J, Huygen K, Aaby P, McAdam KP, Newport MJ. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol 1999; 163(4):2249-2255.
87. + T lymphocytes. Eur J Immunol 2001; 31(5):1531-1535.
88. Ota MOC, Vekemans J, Schlegel-Haueter SE, Fielding K, Sanneh M, Kidd M, Newport MJ, Aaby P, Whittle H, Lambert PH, McAdam KP, Siegrist CA, Marchant A. Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002; 168(2):919-925.
89. Bakir M, Tükenmez F, Bahçeciler NN, Barlan IB, Basaran MM. Heat-killed Mycobacterium bovis-bacillus Calmette Guerin-suppressed total serum IgE response in ovalbumin-sensitized newborn mice. J Asthma 2000; 37(4):329-334.
90. Nahori MA, Lagranderie M, Lefort J, Thouron F, Joseph D, Winter N, Gicquel B, Lapa e Silva JR, Vargaftig BB. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE Bp2 mice vaccinated as newborns. Vaccine 2001; 19(11-12):1484-1495.
91. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G. Infection of mice with Mycobacterium bovis-bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998; 187(4):561-569.
92. Tükenmez F, Bahçeciler NN, Barlan IB, Basaran MM. Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin-sensitized newborn mice. Pediatr Allergy Immunol 1999; 10(2):107-111.
93. Koh YI, Choi IS, Kim WY. BCG infection in allergen-presensitized rats suppresses Th2 immune response and prevents the development of allergic asthmatic reaction. J Clin Immunol 2001; 21(1):51-59.
94. Hopfenspirger MT, Agrawal DK. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002; 168(5):2516-2522.
95. Yang X, Fan Y, Wang S, Han X, Yang J, Bilenki L, Chen L. Mycobacterial infection inhibits established allergic inflammatory responses via alteration of cytokine production and vascular cell adhesion molecule-1 expression. Immunology 2002; 105(3):336-343.
96. Wang C-C, Rook GAW. Inhibition of an established allergic response to ovalbumin in Balb/C mice by killed Mycobacterium vaccae. Immunology 1998; 93(3):307-313.
97. Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunei LR, Kemeny DM, Bowen G, Rook G, Walker C. Suppression of airway eosinophilia by killed Mycobacterium vaccoe-induced allergen-specific regulatory T-cells. Nat Med 2002; 8(6):625-629.
98. Zuany-Amorim C, Manlius C, Trifilieff A, Brunet LR, Rook G, Bowen G, Pay G, Walker C. Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J Immunol 2002; 169(3):1492-1499.
99. Herz U, Gerhold K, Grüber C, Braun A, Wahn U, Renz H, Paul K. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998; 102(5):867-874.
100. Hopfenspirger MT, Parr SK, Townley RG, Agrawal DK. Attenuation of allergic airway inflammation and associated pulmonary functions by mycobacterial antigens is independent of IgE in a mouse model of asthma. Allergol Intern 2002; 51:21-32.
101. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (Srl 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001; 107(3):531-534.
102. Arkwright PD, David TJ. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. Br J Dermatol 2003; 149(5):1029-1034.
103. Camporota L, Corkhill A, Long H, Lordan J, Stanciu L, Tuckwell N, Cross A, Stanford JL, Rook GA, Holgate ST, Djukanovic R. The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur Respir J 2003; 21(2):287-293.
104. Shirtcliffe PM, Easthope SE, Cheng S, Weatherall M, Tan PL, Le Gros G, Beasley R. The effect of delipidated deglycolipidated (Ddmv) and heat-killed Mycobacterium vaccae in asthma. Am J Respir Crit Care Med 2001; 163(6):1410-1414.
105. von Mutius E, Pearce N, Beasley R, Cheng S, von Ehrenstein O, Björkstén B, Weiland S. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 2000; 55(6):449-453.
106. Shirtcliffe P, Weatherall M, Beasley R. An inverse correlation between estimated tuberculosis notification rates and asthma symptoms. Respirology 2002; 7(2):153-155.
107. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275:77-79.
108. Yilmaz M, Bingöl G, Altintas D, Kendirli SG. Correlation between atopic diseases and tuberculin responses. Allergy 2000; 55(7):664-667.
109. Wong GWK, Hui DSC, Tarn CM, Chan HH, Fok TF, Chan-Yeung M, Lai CKW. Asthma, atopy and tuberculin responses in Chinese schoolchildren in Hong Kong. Thorax 2001; 56(10):770-773.
110. Grüber C, Kulig M, Bergmann R, Guggenmoos-Holzmann I, Wahn U, MAS-90 Study Group. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early bacille Calmette-Guerin-vaccinated and nonvaccinated children. Pediatrics 2001; 107(3):E36.
111. Jang AS, Son MH. The association of airway hyperresponsiveness and tuberculin responses. Allergy 2002; 57(4):341-345.
112. Ozmen S, Tomac N, Uysal A, Arslan Z, Kuyucu N, Yoney A. Tuberculin responses in children with allergic diseases. Allergy 2002; 57(11):1059-1062.
113. Ota MOC, van der Sande MAB, Walraven GEL, Jeffries D, Nyan OA, Marchant A, McAdam KPWJ. Absence of association between delayed type hypersensitivity to tuberculin and atopy in children in the Gambia. Clin Exp Allergy 2003; 33(6):731-736.
114. Strannegård IL, Larsson LO, Wennergren G, Strannegård Ö. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 1998; 53(3):249-254.
115. Omenaas E, Jentoft HF, Vollmer WM, Buist AS, Gulsvik A. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax 2000; 55(6):454-458.
116. 1 and bronchial hyperresponsiveness in BCG vaccinated young adults. Allergy 2002; 57(4):336-340.
117. Nurse B, Puterman AS, Haus M, Berman D, Weinberg EG, Potter PC. Pbmcs from both atopic asthmatic and nonatopic children show a Th2 cytokine response to house dust mite allergen. J Allergy Clin Immunol 2000; 106(1 Pt 1):84-91.
118. Julge K, Meriste S, Kemp A, Björkstén B. Atopic allergy and delayed type hypersensitivity in Estonian children. Clin Exp Allergy 2002; 32(10):1420-1423.
119. Smart JM, Kemp AS. Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin Exp Allergy 2002; 32(5):796-802.
120. von Hertzen L, Klaukka T, Mattila H, Haahtela T. Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions. J Allergy Clin Immunol 1999; 104(6):1211-1214.
121. Grüber C, Meinlschmidt G, Bergmann R, Wahn U, Stark K. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr Allergy Immunol 2002; 13(3):177-181.
122. Aaby P, Shaheen SO, Heyes CB, Goudiaby A, Hall AJ, Shiell AW, Jensen H, Marchant A. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000; 30(5):644-650.
123. Aim JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 1997; 350(9075):400-403.
124. Eager P, Rostgaard K, Nielsen NM, Melbye M, Westergaard T. Age at bacille Calmette-Guérin vaccination and risk of allergy and asthma. Clin Exp Allergy 2003; 33(11):1512-1517.
125. Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, Mills KH. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis 1997; 175(5):1246-1250.
126. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 1997; 65(6):2168-2174.
127. Ryan M, Murphy G, Ryan E, Nilsson L, Shackley F, Gothefors L, Øymar K, Miller E, Storsaeter J, Mills KHG. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 1998; 93(1):1-10.
128. Ryan EJ, Nilsson L, Kjellman N-IM, Gothefors L, Mills KHG. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin Exp Immunol 2000; 121(2):193-200.
129. Schuster A, Hofmann A, Reinhardt D. Does pertussis infection induce manifestation of allergy? Clin Investig 1993; 71(3):208-213.
130. Grüber C, Nilsson L, Björkstén B. Do early childhood immunizations influence the development of atopy and do they cause allergic reactions? Pediatr Allergy Immunol 2001; 12(6):296-311.
131. Odent MR, Culpin EE, Kimmel T. Pertussis vaccination and asthma: is there a link? JAMA 1994; 272(8):592-593.
132. Kemp T, Pearce N, Fitzharris P, Crane J, Fergusson D, St. George I, Wickens K, Beasley R. Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology 1997; 8(6):678-680.
133. Nilsson L, Kjellman NI, Storsaeter J, Gustafsson L, Olin P. Lack of association between pertussis vaccination and symptoms of asthma and allergy. JAMA 1996; 275(10):760.
134. Nilsson L, Kjellman NI, Björkstén B. A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch Pediatr Adolesc Med 1998; 152(8):734-738.
135. Grüber C, Lau S, Dannemann A, Sommerfeld C, Wahn U, Aalberse RC. Down-regulation of IgE and IgG4 antibodies to tetanus toxoid and diphtheria toxoid by covaccination with cellular Bordetella pertussis vaccine. J Immunol 2001; 167(4):2411-2417.
136. Wjst M, Dold S, Reitmeir P, Fritzsch C, von Mutius E, Thiemann HH. Pertussis infection and allergic sensitization. Ann Allergy 1994; 73(5):450-454.
137. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296(5567):490-494.
138. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A 1993; 90(3):948-952.
139. Cooke A, Tonks P, Jones FM, O'Shea H, Hutchings P, Fulford AJ, Dunne DW. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999; 21(4):169-176.
140. Williams ME, Montenegro S, Domingues AL, Wynn TA, Teixeira K, Mahanty S, Coutinho A, Sher A. Leukocytes of patients with Schistosoma mansoni respond with a Th2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens. J Infect Dis 1994; 170(4):946-954.
141. Montenegro SM, Miranda P, Mahanty S, Abath FG, Teixeira KM, Coutinho EM, Brinkman J, Gonçalves I, Domingues LA, Domingues AL, Sher A, Wynn TA. Cytokine production in acute versus chronic human Schistosomiasis mansoni: the cross-regulatory role of interferon-gamma and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens. J Infect Dis 1999; 179(6):1502-1514.
142. Marguerite M, Gallissot MC, Diagne M, Moreau C, Diakkhate MM, Roberts M, Remoue F, Thiam A, Decam C, Rogerie F, Cottrez F, Neyrinck JL, Butterworth AE, Sturrock RF, Piau JP, Daff B, Niang M, Wolowczuk I, Riveau G, Auriault C, Capron A. Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cells. Trop Med Int Health 1999; 4(8):530-543.
143. King CL, Medhat A, Malhotra I, Nafeh M, Helmy A, Khaudary J, Ibrahim S, El-Sherbiny M, Zaky S, Stup RJ, Burustoski K, Shehata M, Shata MT. Cytokine control of parasite-specific anergy in human urinary Schistosomiasis. J Immunol 1996; 156:4715-4721.
144. Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, Alvarez N. Effect of anthelmimic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 1993; 92(3):404-411.
145. Dutra WO, Correa-Oliveira R, Dunne D, Cecchini LF, Fraga L, Roberts M, Soares-Silveira AM, Webster M, Yssel H, Gollob KJ. Polarized Th2 like cells, in the absence of Th0 cells, are responsible for lymphocyte produced IL-4 in high IgE-producer Schistosomiasis patients. BMC Immunol 2002; 3(1):8.
146. Sabin EA, Araujo MI, Carvalho EM, Pearce EJ. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 1996; 173(1):269-272.
147. Sartono E, Kruize YC, Kurniawan A, Maizels RM, Yazdanbakhsh M. In Th2-biased lymphatic filarial patients, responses to purified protein derivative of Mycobacterium tuberculosis remain Th1. Eur J Immunol 1996; 26(2):501-504.
148. van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Decider AM, Kremsner PG, Yazdanbakhsh M. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356:1723-1727.
149. Araujo MI, Lopes AA, Medeiros M, Cruz AA, Sousa-Atta L, Sole D, Carvalho EM. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol 2000; 123(2):145-148.
150. Scrivener S, Yemaneberhan H, Zebenigus M, Tilahun D, Girma S, Ali S, McElroy P, Custovic A, Woodcock A, Pritchard D, Venn A, Britton J. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 2001; 358:1493-1499.
151. Lynch NR, Palenque M, Hagel I, DiPrisco MC. Clinical improvement of asthma after anthelminthic treatment in a tropical situation. Am J Respir Crit Care Med 1997; 156(1):50-54.
152. King CL, Mahanty S, Kumaraswami V, Abrams JS, Regunathan J, Jayaraman K, Ottesen EA, Nutman TB. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest 1993; 92(4):1667-1673.
153. Doetze A, Satoguina J, Burchard G, Rau T, Löliger C, Fleischer B, Hoerauf A. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th3/Tr1-type cytokines IL-10 and transforming growth factor-B but not by a Th1 to Th2 shift. Int Immunol 2000; 12(5):623-630.
154. Matricardi PM, Rosmini F, Panetta V, Ferrigno L, Bonini S. Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 2002; 110(3):381-387.
155. Linneberg A, Østergaard C, Tvede M, Andersen LP, Nielsen NH, Madsen F, Frølund L, Dirksen A, Jørgensen T. Igg antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen allergy study. J Allergy Clin Immunol 2003; 111(4):847-853.
156. Bodner C, Anderson WJ, Reid TS, Godden DJ, the Aberdeen WHEASE Study Group. Childhood exposure to infection and risk of adult onset wheeze and atopy. Thorax 2000; 55(5):383-387.
157. Matricardi PM, Bonini S. High microbial turnover rate preventing atopy, a solution to inconsistencies impinging on the hygiene hypothesis? Clin Exp Allergy 2000; 30(11):1506-1510.
158. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159(4):1739-1745.
159. Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999; 69(suppl):1046S-1051S.
160. Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108(4):516-520.
161. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107(1):129-134.
162. Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001; 32(1):1-7.
163. Wickens K, Pearce N, Crane J, Beasley R. Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy 1999; 29(6):766-771.
164. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-1079.
165. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99(2):179-185.
166. Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30:1604-1610.
167. Pessi T, Siitas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000; 30(12):1804-1808.
168. Rautava S, Kalliomäki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109(1):119-121.
169. Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 2000; 68(6):3581-3586.
170. Karlsson H, Hessle C, Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 2002; 70(12):6688-6696.
171. Prescott SL, Taylor A, King B, Dunstan J, Upham JW, Thornton CA, Holt PG. Neonatal interleukin-12 capacity is associated with variations in allergen-specific immune responses in the neonatal and postnatal periods. Clin Exp Allergy 2003; 33(5):566-572.
172. Aim JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999; 353(9163):1485-1488.
173. Filipiak B, Heinrich J, Schäfer T, Ring J, Wichmann HE. Farming, rural lifestyle and atopy in adults from Southern Germany-results from the Monica/Kora Study Augsburg. Clin Exp Allergy 2001; 31(12):1829-1838.
174. Portengen L, Sigsgaard T, Omland Ø, Hjort C, Heederik D, Doekes G. Low prevalence of atopy in young Danish farmers and farming students born and raised on a farm. Clin Exp Allergy 2002; 32(2):247-253.
175. Wickens K, Lane JM, Fitzharris P, Siebers R, Riley G, Douwes J, Smith T, Crane J. Farm residence and exposures and the risk of allergic diseases in New Zealand children. Allergy 2002; 57(12):1171-1179.
176. Ernst P, Cormier Y. Relative scarcity of asthma and atopy among rural adolescents raised on a farm. Am J Respir Crit Care Med 2000; 161(5):1563-1566.
177. Downs SH, Marks GB, Mitakakis TZ, Lëuppi JD, Car NG, Peat JK. Having lived on a farm and protection against allergic diseases in Australia. Clin Exp Allergy 2001; 31(4):570-575.
178. Braun-Fahrländer C, Gassner M, Grize L, Neu U, Sennhauser FH, Varonier HS, Vuille JC, Wüthrich B. Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. Scarpol Team. Swiss study on childhood allergy and respiratory symptoms with respect to air pollution. Clin Exp Allergy 1999; 29(1):28-34.
179. Riedler J, Eder W, Oberfeld G, Schreuer M. Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy 2000; 30(2):194-200.
180. Riedler J, Braun-Fahrländer C, Eder W, Schreuer M, Waser M, Maisch S, Carr D, Schierl R, Nowak D, von Mutius E. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001; 358(9288):1129-1133.
181. Gassner-Bachmann M, Wüthrich B. Bauernkinder leiden selten an Heuschnupfen und Asthma [Farmers' children suffer less from hay fever and asthma] [German with English abstract]. Dtsch Med Wochenschr 2000; 125(31-32):924-931.
182. von Ehrenstein OS, von Mutius E, Illi S, Baumann L, Böhm O, von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy 2000; 30(2):187-193.
183. Leynaert B, Neukirch C, Jarvis D, Chinn S, Burney P, Neukirch F. Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am J Respir Crit Care Med 2001; 164(10 Pt 1):1829-1834.
184. Remes ST, Iivanainen K, Koskela H, Pekkanen J. Which factors explain the lower prevalence of atopy amongst farmers' children? Clin Exp Allergy 2003; 33(4):427-434.
185. von Mutius E, Braun-Fahrländer C, Schierl R, Riedler J, Ehlermann S, Maisch S, Waser M, Nowak D. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000; 30(9):1230-1234.
186. Braun-Fahrländer C. Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: evaluating developments since April 2002. Curr Opin Allergy Clin Immunol 2003; 3(5):325-329.
187. Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD, Liu AH. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000; 355(9216):1680-1683.
188. Michel O. Systemic and local airways inflammatory response to endotoxin. Toxicology 2000; 152(1-3):25-30.
189. Kline JN, Cowden JD, Hunninghake GW, Schutte BC, Watt JL, Wohlford-Lenane CL, Powers LS, Jones MP, Schwartz DA. Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med 1999; 160(1):297-303.
190. Park JH, Gold DR, Spiegelman DL, Burge HA, Milton DK. House dust endotoxin and wheeze in the first year of life. Am J Respir Crit Care Med 2001; 163(2):322-328.
191. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ, The Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332(3):133-138.
192. Braun-Fahrländer C, Riedler J, Herz U, Eder W, Waser M, Grize L, Maisch S, Carr D, Gerlach F, Bufe A, Lauener RP, Schierl R, Renz H, Nowak D, von Mutius E. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347(12):869-877.
193. Gehring U, Bischof W, Fahlbusch B, Wichmann HE, Heinrich J. House dust endotoxin and allergic sensitization in children. Am J Respir Crit Care Med 2002; 166(7):939-944.
194. Sroka J. Seroepidemiology of toxoplasmosis in the Lublin region. Ann Agric Environ Med 2001; 8(1):25-31.
195. O'Brien SJ, Adak GK, Gilham C. Contact with farming environment as a major risk factor for Shiga toxin (Vero cytotoxin)-producing Escherichia coli 0157 infection in humans. Emerg Infect Dis 2001; 7(6):1049-1051.
196. Papiez D, Konturek PC, Bielanski W, Plonka M, Dobrzanska M, Kaminska A, Szczyrk U, Bochenek A, Wierzchos E. Prevalence of Helicobacter pylori infection in Polish shepherds and their families. Dig Liver Dis 2003; 35(1):10-15.
197. Böttcher MF, Björkstén B, Gustafson S, Voor T, Jenmalm MC. Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy 2003; 33(3):295-300.
198. von Mutius E. The influence of birth order on the expression of atopy in families: a gene-environment interaction? [Editorial]. Clin Exp Allergy 1998; 28(12):1454-1456.
199. Karmaus W, Arshad H, Mattes J. Does the sibling effect have its origin in utero? Investigating birth order, cord blood immunoglobulin E concentration, and allergic sensitization at age 4 years. Am J Epidemiol 2001; 154(10):909-915.
200. Warner JA, Miles EA, Jones AC, Quint DJ, Colwell BM, Warner JO. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema? Clin Exp Allergy 1994; 24(5):423-430.
201. Kondo N, Kobayashi Y, Shinoda S, Takenaka R, Teramoto T, Kaneko H, Fukao T, Matsui E, Kasahara K, Yokoyama Y. Reduced interferon gamma production by antigen-stimulated cord blood mononuclear cells is a risk factor of allergic disorders-6-year follow-up study. Clin Exp Allergy 1998; 28(11):1340-1344.
202. van der Velden VH, Laan MP, Baert MR, de Waal Malefyt R, Neijens HJ, Savelkoul HF. Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of Ifn-gamma, IL-4 and IL-10. Clin Exp Allergy 2001; 31(7):997-1006.
203. Hattevig G, Kjellman B, Björkstén B. Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol 1993; 4(4):182-186.
204. Sigurs N, Hattevig G, Kjellman B, Kjellman NI, Nilsson L, Björkstén B. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol 1994; 94(4):757-763.
205. Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999; 103(6):1173-1179.
206. Kulig M, Klettke U, Wahn V, Forster J, Bauer C-P, Wahn U. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000; 106(5):832-839.
207. Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999; 54(3):268-272.
208. Faniran AO, Peat JK, Woolcock AJ. Prevalence of atopy, asthma symptoms and diagnosis, and the management of asthma: comparison of an affluent and a non-affluent country. Thorax 1999; 54(7):606-610.
209. Gardner SG, Bingley PJ, Sawtell PA, Weeks S, Gale EA. Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Bart's-Oxford Study Group. BMJ 1997; 315(7110):713-717.
210. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type I diabetes-the analysis of the data on published incidence trends. Diabetologia 1999; 42(12):1395-1403.
211. Green A, Patterson CC. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 2001; 44(suppl 3):B3-B8.
212. Stene LC, Nafstad P. Relation between occurrence of type 1 diabetes and asthma [letter]. Lancet 2001; 357:607-608.
213. Kero J, Gissler M, Hemminki E, Isolauri E. Could Th1 and Th2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol 2001; 108:781-783.
214. Simpson CR, Anderson WJ, Helms PJ, Taylor MW, Watson L, Prescott GJ, Godden DJ, Barker RN. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy 2002; 32(1):37-42.
215. Sheikh A, Smeeth L, Hubbard R. There is no evidence of an inverse relationship between Th2-mediated atopy and Th1-mediated autoimmune disorders: lack of support for the hygiene hypothesis. J Allergy Clin Immunol 2003; 111(1):131-135.
216. Allanore Y, Hilliquin P, Coste J, Renoux M, Menkes CJ. Decreased prevalence of atopy in rheumatoid arthritis. Lancet 1998; 351:497.
217. Oro AS, Guarino TJ, Driver R, Steinman L, Umetsu DT. Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 1996; 97:1402-1408.
218. Cardwell CR, Shields MD, Carson DJ, Patterson CC. A meta-analysis of the association between childhood type 1 diabetes and atopic disease. Diabetes Care 2003; 26(9):2568-2574.
219. Borchers AT, Kuhl SJ, Keen CL, Meroni PL, Gershwin ME. Cytokines, chemokines, and their cognate receptors in autoimmune diseases. Semin Clin Immunol 1999; 18:17-39.
220. Thepen T, Langeveld-Wildschut EG, Bihari IC, van Wichen DF, van Reijsen FC, Mudde GC, Bruijnzeel-Koomen CA. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996; 97(3):828-837.
221. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1(1):69-75.
222. Yazdanbakhsh M, van den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 2001; 22(7):372-377.
223. Matricardi PM, Yazdanbakhsh M. Mycobacteria and atopy, 6 years later: a fascinating, still unfinished, business [editorial]. Clin Exp Allergy 2003; 33(6):717-720.
224. Rona RJ, Hughes JM, Chinn S. Association between asthma and family size between 1977 and 1994. J Epidemiol Community Health 1999; 53(1):15-19.